Profile
Edwin L.
Madison formerly worked at Dendreon Corp., as Vice President-Biological Research, Catalyst Bioscience, Inc., as Chief Scientific Officer, The Scripps Research Institute, as Associate Professor-Vascular Biology from 2012 to 2013, The University of Texas at Austin, as Principal, Torrey Pines Institute For Molecular Studies, Inc., as Professor-Vascular Biology, and Catalyst Biosciences, Inc., as Chief Scientific Officer from 2006 to 2016.
Dr. Madison received his doctorate degree in 1990 from The University of Texas Southwestern Medical Center.
Former positions of Edwin L. Madison
| Companies | Position | End |
|---|---|---|
| CATALYST BIOSCIENCES | Chief Tech/Sci/R&D Officer | 09/09/2016 |
| The University of Texas at Austin | Corporate Officer/Principal | - |
Torrey Pines Institute For Molecular Studies, Inc.
 Torrey Pines Institute For Molecular Studies, Inc. Miscellaneous Commercial ServicesCommercial Services Torrey Pines Institute for Molecular Studies, Inc. operates as a non-profit research center. The firm conducts research in various fields including: multiple sclerosis, cancer, heart disease, types I and II diabetes, macular degeneration, pain management, alzheimer's disease, inflammatory disorders, AIDS and other infectious diseases, regenerative medicine, obesity, transplant rejection, muscle wasting syndrome, rheumatoid arthritis and new methods for drug discovery. The company was founded by Dr. Richard A. Houghten in 1988 and is headquartered in Port St. Lucie, FL. | Corporate Officer/Principal | - |
The Scripps Research Institute
 The Scripps Research Institute Other Consumer ServicesConsumer Services The Scripps Research Institute is a private, non-profit research organizations that performs basic biomedical research in molecular & cellular biology, chemistry, immunology and neuroscience. They receive the majority of its funding from federal agencies such as the National Institutes of Health. The organization also partners with pharmaceutical companies and is affiliated with the Scripps hospital group. The organization was founded in 1955 and is headquartered in La Jolla, California. | Corporate Officer/Principal | - |
| DENDREON CORPORATION | Corporate Officer/Principal | - |
Training of Edwin L. Madison
| The University of Texas Southwestern Medical Center | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Catalyst Bioscience, Inc. /Old/
 Catalyst Bioscience, Inc. /Old/ Medical SpecialtiesHealth Technology Catalyst Bioscience, Inc. develops and markets catalytic biopharmaceutical products. Its technology consists of methods to identify proteases with tailor-made specificity or improved pharmacological properties. The company was founded by Charles Craik, Sandra Waugh Ruggles and Christopher Thanos in 2003 and is headquartered in South San Francisco, CA. | Health Technology |
Dendreon Corp.
 Dendreon Corp. Medical SpecialtiesHealth Technology Dendreon Corp. discovers, develops and commercializes novel products for the treatment of cancer. The company applies its expertise in antigen identification, engineering and cell processing to produce active cellular immunotherapy ACI product candidates designed to stimulate an immune response in a variety of tumor types. It is an exploring the application of additional ACI product candidates and small molecules for the potential treatment of a variety of cancers. Dendreon was founded by Christopher S. Henney, Edgar G. Engleman and Samuel Strober in 1992 and is headquartered in Seattle, WA. | Health Technology |
Torrey Pines Institute For Molecular Studies, Inc.
Torrey Pines Institute For Molecular Studies, Inc. Miscellaneous Commercial ServicesCommercial Services Torrey Pines Institute for Molecular Studies, Inc. operates as a non-profit research center. The firm conducts research in various fields including: multiple sclerosis, cancer, heart disease, types I and II diabetes, macular degeneration, pain management, alzheimer's disease, inflammatory disorders, AIDS and other infectious diseases, regenerative medicine, obesity, transplant rejection, muscle wasting syndrome, rheumatoid arthritis and new methods for drug discovery. The company was founded by Dr. Richard A. Houghten in 1988 and is headquartered in Port St. Lucie, FL. | Commercial Services |
Catalyst Biosciences, Inc.
 Catalyst Biosciences, Inc. BiotechnologyHealth Technology Catalyst Biosciences, Inc. operates as a clinical-stage biopharmaceutical company. It engages in the development of novel medicines to address serious medical conditions. The company was founded on March 7, 1997 and is headquartered in South San Francisco, CA. | Health Technology |
- Stock Market
- Insiders
- Edwin L. Madison
